Human adrenocortical carcinoma cell lines
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Summary The human adrenal cortex secretes mineralocorticoids, glucocorticoids and adrenal androgens. These steroids are produced from unique cell types located within the three distinct zones of the adrenal cortex. Disruption of adrenal steroid production results in a variety of diseases that can lead to hypertension, metabolic syndrome, infertility and androgen excess. The adrenal cortex is also a common site for the development of adenomas, and rarely the site for the development of carcinomas. The adenomas can lead to diseases associated with adrenal steroid excess, while the carcinomas are particularly aggressive and have a poor prognosis. In vitro cell culture models provide an important tool to examine molecular and cellular mechanisms controlling both the normal and pathologic function of the adrenal cortex. Herein we discuss the human adrenocortical cell lines and their use as model systems for adrenal studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling
Giordano, T. J., Kuick, R., Else, T., Gauger, P. G., Vinco, M., Bauersfeld, J., Sanders, D., Thomas, D. G., Doherty, G., & Hammer, G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1067 · Cited by 401
Adrenocortical carcinoma: a clinician’s update
Fassnacht, M., Libé, R., Kroiss, M., & Allolio, B. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.235 · Cited by 396 · cited 2×
“, 1993), and later adopted as an anti-adrenocortical carcinoma drug (Veytsman et al., 2009; Bertagna, 2010; Fassnacht et al., 2011).”
Backgroundde Reyniès, A., Assié, G., Rickman, D. S., Tissier, F., Groussin, L., René-Corail, F., Dousset, B., Bertagna, X., Clauser, E., & Bertherat, J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.5678 · Cited by 382 · cited 1×
“3). de Reynies et al. (2009) found that DLG7 (Discs large homolog 7), PINK1 (PTEN induced putative kinase 1) and BUB1B (budding uninhibited by benzimidazoles 1 homolog beta) were related to the outcome prognosis of adrenocortical carcinoma.”
BackgroundPreclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma
Barlaskar, F. M., Spalding, A. C., Heaton, J. H., Kuick, R., Kim, A. C., Thomas, D. G., Giordano, T. J., Ben-Josef, E., & Hammer, G. D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1456 · Cited by 189
Almeida, M. Q., Fragoso, M. C. B. V., Lotfi, C. F. P., Santos, M. G., Nishi, M. Y., Costa, M. H. S., Lerario, A. M., Maciel, C. C., Mattos, G. E., Jorge, A. A. L., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0065 · Cited by 176 · cited 4×
“Cell Line Name Ang II K+ ACTH cAMP Steroids produced Reference NCI-H295 ND ND _ + Mineralocorticoids Glucocorticoids Adrenal androgens Gazdar et al. (1990), Staels et al. (1993), Rainey et al. (1994) NCI-H295A _ ND _ + Mineralocorticoid Glucocorticoids Adrenal androgens Rodriguez et al. (1997) NCI-H295R strains + + /+…”
BackgroundMethodInfluentialThe effects of ACTH on steroid metabolomic profiles in human adrenal cells
Xing, Y., Edwards, M. A., Ahlem, C., Kennedy, M., Cohen, A., Gomez-Sanchez, C. E., & Rainey, W. E. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0493 · Cited by 101 · cited 5×
“These cells produce an array of steroids even under basal conditions (Rainey et al., 1994; Xing et al., 2011).”
BackgroundDenner, K., Rainey, W. E., Pezzi, V., Bird, I. M., Bernhardt, R., & Mathis, J. M. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(96)03853-1 · Cited by 85
Self-citationACTH is a Potent Regulator of Gene Expression in Human Adrenal Cells
Xing, Y., Parker, C. R., Edwards, M., & Rainey, W. E. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0006 · Cited by 83
Self-citationOverexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome
Schteingart, D. E., Giordano, T. J., Benitez, R. S., Burdick, M. D., Starkman, M. N., Arenberg, D. A., & Strieter, R. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7780 · Cited by 45 · cited 2×
“Assessments of adrenocortical function showed atypical steroidogenesis, and lack of response upon ACTH stimulation (Schteingart et al., 2001).”
BackgroundMethodSchteingart, D. E., Sinsheimer, J. E., Counsell, R. E., Abrams, G. D., McClellan, N., Djanegara, T., Hines, J., Ruangwises, N., Benitez, R., & Wotring, L. L. (1993) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685036 · Cited by 38 · cited 2×
“Another proposed anticancer drug, mitotane, strongly suppressed cell growth of NCIH295 cells (Schteingart et al., 1993), and later adopted as an anti-adrenocortical carcinoma drug (Veytsman et al.”
Background
Cited by
Development of monoclonal antibodies against human CYP11B1 and CYP11B2
Gomez-Sanchez, C. E., Qi, X., Velarde-Miranda, C., Plonczynski, M. W., Parker, C. R., Rainey, W., Satoh, F., Maekawa, T., Nakamura, Y., Sasano, H., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.11.022 · Cited by 283
Self-citationRegulation of aldosterone synthesis and secretion.
Bollag, W. B. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130037 · Cited by 180
Advances in the analytical methodologies: profiling steroids in familiar pathways-challenging dogmas
Bloem, L. M., Storbeck, K.-H., Swart, P., du Toit, T., Schloms, L., & Swart, A. C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.04.009 · Cited by 52
Age-dependent increases in adrenal cytochrome b5 and serum 5-androstenediol-3-sulfate
Rege, J., Karashima, S., Lerario, A. M., Smith, J. M., Auchus, R. J., Kasa-Vubu, J. Z., Sasano, H., Nakamura, Y., White, P. C., & Rainey, W. E. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2864 · Cited by 40
“The expression of CYB5A was silenced in HAC15 adrenocortical cells (28) using GIPZ lentiviral short hairpin RNA (shRNA) technology (Supplemental File).”
MethodSelf-citationKempná, P., Marti, N., Udhane, S., & Flück, C. E. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.015 · Cited by 29
Metadata
- Authors
- Wang, T., & Rainey, W. E.
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 351
- Issue
- 1
- Pages
- 58-65
- ISSN
- 0303-7207 (ISSN-L)
- OpenAlex
- W2060610536
- Cited by
- 147
- References
- 10
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.